Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CatenaBio Logo
CatenaBio Growth Score
86
CB Rank
534962
Heat Score
61
CatenaBio develops protein conjugation technologies for personalized therapeutics using its CysTyr™ technology.
Founded
obfuscation
Private Berkeley, California, United States1-10 catenabio.com
Analytics
Biopharma
Biotechnology
Clinical Trials
Overview

CatenaBio
Growth Score
86
Heat Score
61

Growth Score86
-3 pts
in past quarter
Heat Score 61
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About CatenaBio

CB Rank
534962
CatenaBio develops protein conjugation technologies for personalized therapeutics using its CysTyr™ technology.
Founded
obfuscation
Private Berkeley, California, United States1-10 catenabio.com
Analytics
Biopharma
Biotechnology
Clinical Trials

Key People

Details

Legal Name CatenaBio, Inc.
Operating Status Active
Company Type For Profit
About the Company

CatenaBio pioneers protein conjugation technologies for novel therapeutic development. The company focuses on creating innovative, personalized therapeutics using its proprietary CysTyr™ technology. This technology allows precise connection to any site on a protein, facilitating the development of multi-payload conjugates. CatenaBio's

advancements have potential applications in biological therapeutics, autoimmune disorders, and vaccine development.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CysTyr™ Technology
A protein conjugation technology that enables site-specific attachment of molecules to proteins using cysteine and tyrosine residues.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 5

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

839
366.11%
 in past month

IT Spend

$59.3KThis year, CatenaBio is projected to spend $59.3K on IT, according to Aberdeen.

Active Website Tech Count

5CatenaBio is actively using 5 technologies for its website, according to BuiltWith. These include Euro, PayPal, and  CommonCrawl Top 5m.
Sub-Organizations
Frequently Asked Questions

Where is CatenaBio's headquarters? CatenaBio is located in Berkeley, California, United States.Who are CatenaBio's competitors? Alternatives and possible competitors to CatenaBio may include CatalYm, Araris Biotech, and  Sutro Biopharma.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6061015 1)
|